| Akiva Dmitry Gimpelevich, DO | |
|
110 Professional Park, Oxford, NC 27565-2576 | |
| (919) 693-6541 | |
| (919) 693-7396 |
| Full Name | Akiva Dmitry Gimpelevich |
|---|---|
| Gender | Male |
| Speciality | |
| Experience | Years |
| Location | 110 Professional Park, Oxford, North Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1467638791 | NPI | - | NPPES |
| 003100972A | Medicaid | GA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207VX0000X | Obstetrics & Gynecology - Obstetrics | 64219 (Georgia) | Secondary |
| 207VG0400X | Obstetrics & Gynecology - Gynecology | 64219 (Georgia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Akiva Dmitry Gimpelevich, DO Po Box 986, Oxford, NC 27565-0986 Ph: () - | Akiva Dmitry Gimpelevich, DO 110 Professional Park, Oxford, NC 27565-2576 Ph: (919) 693-6541 |
News Archive
"Republican victories in two gubernatorial elections are casting a shadow on House Democratic efforts to secure support from wavering members for health-care legislation," Dow Jones Newswires/The Wall Street Journal reports. "The GOP is framing the outcome as a rejection of Democratic proposals including the health-care bill, and some conservative and vulnerable Democrats seem inclined to agree, as they keep an eye on 2010 elections" (Vaughan, 11/4).
Allos Therapeutics, Inc. today announced the presentation of favorable survival data from the Company's international, randomized Phase 2b investigational study of FOLOTYN relative to erlotinib in patients with Stage IIIB/IV (advanced) non-small cell lung cancer (NSCLC). In this study, patients receiving FOLOTYN had a 16 percent reduction in the risk of death compared to erlotinib in the overall (intent-to-treat) population.
A federal appeals court in Denver said Thursday that companies, whether they are for profit or not, have religious rights and that the challenge brought by Hobby Lobby Stores Inc. and its sister company can go forward.
GlaxoSmithKline and XenoPort, Inc. announced today that the U.S. Food and Drug Administration (FDA) has accepted for review GSK's response to FDA's Complete Response letter for Horizant (gabapentin enacarbil) Extended-Release Tablets. Horizant is under review for the treatment of moderate-to-severe primary Restless Legs Syndrome (RLS).
› Verified 6 days ago
Dr. Kayla Jeanne Cagle-colon, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1209 Se Industry Dr, Oxford, NC 27565 Phone: 252-492-8576 | |
Dr. Lakeya Charron Russell, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 110 Professional Park, Oxford, NC 27565 Phone: 919-693-6541 Fax: 919-693-7396 | |
Syreeta Alston Tucker, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1209 Se Industry Dr, Oxford, NC 27536 Phone: 252-492-8576 Fax: 252-492-7464 | |
James Weldon Hampton, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1209 Se Industry Drive, Oxford, NC 27565 Phone: 919-693-9998 Fax: 919-690-0334 | |
Dr. James Andrew Mccarthy Sr., MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 102 Professional Park Ste A, Oxford, NC 27565 Phone: 919-603-5051 | |
Stacy B Lewis Jr., M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 101 Professional Park, Oxford, NC 27565 Phone: 919-693-1082 Fax: 919-693-2726 |